GBP · £
USD · $
EUR · €
CAD · C$
AUD · A$
Retatrutide
Triple GIP/GLP-1/glucagon agonist · laboratory research material
A Retatrutide research vial presented with clear multi-receptor context, verified contents and strict separation between research evidence and consumer claims.
Subscribe for updates
This product is coming soon. Leave your email and we will notify you when Retatrutide is in stock.
You would earn 49 points
- 5mgStrength
- ≥99% HPLCPurity target
- UK dispatchFrom the UK
- CoAOn request
Free UK shipping over £100
900+ reviews · trusted product quality
HPLC purity documentation
Dispatched from the UK
APH Peptides Retatrutide is listed as a 5mg lyophilised research peptide for laboratory use - coming soon.
At a glance:
- 5mg lyophilised (freeze-dried) vial
- HPLC purity target ≥99%
- Clear vial + box labelling under APH Peptides
- UK dispatch with tracked UK shipping
- CoA / purity documentation available on request
- Strictly for laboratory research - not for human consumption
Compound Retatrutide Full name Retatrutide Strength 5mg Form Lyophilised powder Purity target ≥99% (HPLC) Class Triple (GIP/GLP-1/glucagon) receptor agonist (research) Status Subscribe below for stock notes Use Laboratory research only
In laboratory and preclinical literature, Retatrutide is studied as a triple (GIP/GLP-1/glucagon) receptor agonist, used in models examining multi-agonist metabolic pathway signalling - a research angle that builds on single- and dual-agonist incretin literature. APH Peptides supplies material for controlled lab protocols only - not for human use.
Supplied as a 5mg lyophilised vial. Labs reconstitute under sterile technique using solvents approved by their institution. Storage, concentration and experimental design sit with your SOP - APH Science does not provide human dosing guidance.
Free UK shipping on all orders over £100. Peptide orders use the same APH Science warehouse workflow with plain, unbranded outer packaging and cold-chain ready packing where needed.
Research peptide batches target HPLC purity of ≥99%. Certificate of Analysis style documentation will be available for research lots. All APH Peptides products are for laboratory research only and are not intended for human consumption.
Testimonials
Key benefits
Three Receptors, One Compound
Retatrutide is studied as a triple (GIP/GLP-1/glucagon) receptor agonist, one of the most-referenced next-generation compounds in multi-agonist metabolic research literature.
Try now
Appetite Regulation
The GLP-1 and GIP arms are studied for their role in appetite signalling, with research comparing triple-agonist engagement against single-agonist compounds in controlled models.
Try now
Energy Use
The glucagon receptor arm is studied for energy expenditure signalling, so triple-agonist research looks at both sides of the energy equation: intake and output.
Try now
Retatrutide 5mg
Retatrutide is the most-referenced next-generation triple agonist in metabolic research. A 5mg lyophilised research peptide with HPLC purity targeting, clear labelling and UK dispatch. For controlled laboratory use only.
-
5mg vialLyophilised research peptide, clearly labelled with batch identity.
-
Triple agonistStudied for GIP, GLP-1 and glucagon receptor activity in one compound.
-
Lab-grade supplyHPLC purity targeting and UK dispatch for controlled research use.
Three receptors. One compound.
Single-agonist compounds hit one receptor. Dual agonists hit two. Retatrutide is studied for activity at three: GIP, GLP-1 and glucagon. That triple engagement is why it sits at the centre of next-generation multi-agonist metabolic research.
-
GIP receptorStudied for its role in nutrient signalling and metabolic pathway models.
-
GLP-1 receptorThe incretin pathway behind the most-cited appetite research.
-
Glucagon receptorThe third arm: energy expenditure signalling in research models.
Appetite regulation
The GLP-1 and GIP arms of Retatrutide are studied for their role in appetite signalling. Research interest centres on how multi-agonist engagement affects hunger pathways and food intake in controlled models, compared with single-agonist compounds.
-
Hunger signallingGLP-1 and GIP pathways are the most-studied appetite signals in incretin research.
-
Multi-agonist modelResearch compares triple engagement against single-agonist compounds.
-
Controlled modelsFindings come from controlled laboratory study designs, not anecdotes.
Energy use
The glucagon arm sets Retatrutide apart. Glucagon receptor activity is studied for its role in energy expenditure, which is why triple-agonist research looks beyond appetite alone. Intake down, output up: that is the model researchers are testing.
-
Energy expenditureGlucagon receptor signalling is studied for its effect on energy output.
-
Beyond appetiteTriple-agonist models look at both sides of the energy equation.
-
Next-generationRetatrutide builds on single and dual-agonist research with a third pathway.
Product FAQs
Contact us Contact usWhat is Retatrutide?
Retatrutide is a research peptide studied as a triple (GIP/GLP-1/glucagon) receptor agonist, used in laboratory and preclinical literature examining multi-agonist metabolic pathway models.
Is Retatrutide available now?
Retatrutide is coming soon. Subscribe on this page and we will email you the moment it is in stock.
What strength will it be supplied at?
5mg lyophilised vial, HPLC purity target ≥99%.
What makes Retatrutide a 'triple agonist'?
Retatrutide is catalogued as engaging GIP, GLP-1 and glucagon receptors simultaneously - a broader multi-agonist research angle than single- or dual-agonist compounds.
How does Retatrutide differ from Semaglutide or Tirzepatide?
Semaglutide is studied as a single GLP-1 agonist, Tirzepatide as a dual GIP/GLP-1 agonist, and Retatrutide as a triple GIP/GLP-1/glucagon agonist - each representing a different point in incretin-receptor research literature.
Is Retatrutide hormonal like an androgen-receptor SARM?
No. Retatrutide's research framing sits within multi-agonist metabolic pathway literature, not androgen receptor agonism.
What does HPLC ≥99% mean?
HPLC (high-performance liquid chromatography) purity testing targets ≥99% for research peptide batches - a quality benchmark, not a medical claim.
Storage for research material
Keep sealed, cool, and dry away from direct light. Follow any lot-specific note supplied with the order.
What makes APH Peptides different for this compound?
Retatrutide will ship under the same UK-owned QC culture as the rest of the APH Science range - clear labelling, third-party testing culture, and plain packaging.
Can I get batch / CoA documentation?
Where certificates of analysis or batch documentation are available for a product, APH Science can supply them on request once stock lands. Include your order number and product name when contacting support.
Where do you ship from?
Orders dispatch from the UK with tracked shipping options. Free UK shipping applies on carts over £100.
How will I know when Retatrutide is back in stock?
Leave your email in the subscribe card on this page - we will notify you as soon as stock lands.
How are orders packed?
Orders go out in plain, unbranded packaging with no external branding. Tracking is provided so you can follow the parcel in transit.
Is every batch third-party tested?
APH Science targets independent lab verification for research batches before release. Certificate or purity paperwork can be requested where available for your lot.
Is this for human consumption?
No. Research compounds, SARMs, and research peptides are sold strictly for laboratory research purposes only. They are not intended for human consumption, medical use, or as food or dietary supplements.
